Cannabis - How Drugs Affect You - References
1. Canna F. What are cannabinoids? Where can cannabinoids be found? n.d. [cited 04.02.2025]
2. Sholler DJ, Schoene L, Spindle TR. Therapeutic Efficacy of Cannabidiol (CBD): A Review of the Evidence from Clinical Trials and Human Laboratory Studies. Curr Addict Rep. 2020. 7(3):405-12. doi: 10.1007/s40429-020-00326-8. [cited 02.05.2025]
3. Lambert Initiative for Cannabinoid Therapeutics. Phytocannabinoids. University of Sydney. [cited May 27]
4. Batalla A, Bos J, Postma A, Bossong MG. The Impact of Cannabidiol on Human Brain Function: A Systematic Review. Vol: 11: 2020. p. 618184. [cited 20.03.2025].
5. Health Direct. Medicinal cannabis. 2022. [cited 02.05.2025]
6. Berger M, Amminger G, McGregor I. Medicinal cannabis for the treatment of anxiety disorders. Australian Journal for General Practitioners. 2022. 51:586-92[cited 02.05.2025]
7. Arnold JC, Nation T, McGregor IS. Prescribing medicinal cannabis. Aust Prescr. 2020. 43(5):152-9. doi: 10.18773/austprescr.2020.052. [cited 02.05.2025]
8. Meacham MC, Paul MJ, Ramo DE. Understanding emerging forms of cannabis use through an online cannabis community: An analysis of relative post volume and subjective highness ratings. Drug and Alcohol Dependence. 2018. 188:364-9.
9. Chan GCK, Hall W, Freeman TP, Ferris J, Kelly AB, Winstock A. User characteristics and effect profile of Butane Hash Oil: An extremely high-potency cannabis concentrate. Drug and Alcohol Dependence. 2017. 178:32-8.
10. MacCallum CA, Russo EB. Practical considerations in medical cannabis administration and dosing. European Journal of Internal Medicine. 2018. 49:12-9.
11. Blake A, Nahtigal I. The evolving landscape of cannabis edibles. Current Opinion in Food Science. 2019. 28:25-31. doi: 10.1016/j.cofs.2019.03.009. [cited 13.05.2025]
12. Queensland Injectors Health Network Queensland Injectors Voice for Advocacy and Action. Cannabis n.d. [cited 30.05.2025]
13. Psychonaut Wiki. Cannabis. 2025. [cited 01.05.2025]
14. Jessica Reilly-Chevalier. What is greening out? What you need to know about consuming too much cannabis. The Cannigma,. 2022. [cited 02.05.2025]
15. Ross Buchanan. Why You Sometimes Feel Sick or Vomit After Smoking Weed. Vice, . 2022. [cited 03.06.2025]
16. Green BOB, Kavanagh D, Young R. Being stoned: a review of self-reported cannabis effects. Drug and Alcohol Review. 2003;22(4):453-60. doi: 10.1080/09595230310001613976. [cited 2020/05/27]
17. NDARC. Cannabis. 2021. [cited 29.04.2025]
18. Rock KL, Englund A, Morley S, Rice K, Copeland CS. Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020). Journal of Psychopharmacology (Oxford, England). 2022. 36(12):1362-70. doi: 10.1177/02698811221115760. [cited 24.04.2025]
19. Zahra E, Darke S, Degenhardt L, Campbell G. Rates, characteristics and manner of cannabis-related deaths in Australia 2000-2018. Drug and Alcohol Dependence. 2020. 212. doi: 10.1016/j.drugalcdep.2020.108028. [cited 29.04.2025]
20. Darke S, Duflou J, Farrell M, Peacock A, Lappin J. Characteristics and circumstances of synthetic cannabinoid-related death. Clinical Toxicology. 2020. 58(5):368-74. doi: 10.1080/15563650.2019.1647344. [cited 05.05.2025]
21. Cohen K, Weinstein AM. Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective. Front Public Health. 2018. 6:162-. doi: 10.3389/fpubh.2018.00162. [cited [18.10.2021]
22. Heart Foundation. Heart attack warning signs. 2024. [cited 24.04.2025]
23. Nutt D. Drugs without the hot air : making sense of legal and illegal drugs. Cambridge: UIT Cambridge Ltd; 2012. [cited 26.11.2024].
24. Darke S, Lappin, J. & Farrell, M. The Clinician's Guide to Illicit Drugs. United Kingdom: Silverback Publishing 2019. [cited 26.11.2024].
25. First Nations Health Authority. Harm Reduction and cannabis - Making choices for safer use n.d. [cited 24.11.2022]
26. National Academies of Sciences Engineering Medicine. The health effects of cannabis and cannabinoids: The current state of evidence and recommendations for research. National Academies Press; 2017.
27. Wilkinson ST, Radhakrishnan R, D’Souza DC. Impact of Cannabis Use on the Development of Psychotic Disorders. Current Addiction Reports. 2014. 1(2):115-28. doi: 10.1007/s40429-014-0018-7. [cited 30.05.2025]
28. Therapeutic Goods Administration. Guidance for the use of medicinal cannabis in Australia: Overview. 2025. [cited 14.05.2025]
29. Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of psychopharmacology (Oxford, England). 2013. 27(1):19-27. doi: 10.1177/0269881112460109. [cited 14.05.2025]
30. Schubart CD, Sommer IEC, van Gastel WA, Goetgebuer RL, Kahn RS, Boks MPM. Cannabis with high cannabidiol content is associated with fewer psychotic experiences. Schizophrenia Research. 2011. 130(1-3):216-21. doi: 10.1016/j.schres.2011.04.017. [cited 14.05.2025]
31. Scott JC, Slomiak ST, Jones JD, Rosen AFG, Moore TM, Gur RC. Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2018;75(6):585-95. doi: 10.1001/jamapsychiatry.2018.0335. [cited 5/29/2020]
32. Lee MHS, Hancox RJ. Effects of smoking cannabis on lung function. Expert Review of Respiratory Medicine. 2011. 5(4):537-47. doi: 10.1586/ers.11.40. [cited 30.05.2025]
33. Psychonaut Wiki. Substance withdrawal 2024. [cited 01.05.2025]
34. Bonnet U, Preuss UW. The cannabis withdrawal syndrome: current insights. Substance Abuse and Rehabilitation. 2017. 8:9-37[cited 02.05.2025]
35. Taylor L, Crockett J, Tayo B, Checketts D, Sommerville K. Abrupt withdrawal of cannabidiol (CBD): A randomized trial. Epilepsy Behav. 2020. 104(Pt A):106938. doi: 10.1016/j.yebeh.2020.106938. [cited 02.05.2025] Available from:
36. Gorelick DA. Diagnosis and Treatment of Cannabis-Related Disorders. Reference Module in Neuroscience and Biobehavioral Psychology: Elsevier; 2024 Available from: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cannabis-induced-psychosis.
37. Academy of Perinatal Harm Reduction. cannabis. 2024. [cited 30.04.2025] Available from: https://www.perinatalharmreduction.org/cannabis.
38. Development NIoCHaH. Drugs and Lactation Database (LactMed®): Cannabis. 2025. [cited 30.04.2025]
39. Lo J, Hedges JC, Girardi G. Impact of cannabinoids on pregnancy, reproductive health, and offspring outcomes. American journal of obstetrics and gynecology. 2022. 227(4):571-81[cited [18.06.24]
40. The Royal Women's Hospital. Using cannabis (marijuana, weed, dope) during pregnancy and breastfeeding. 2021. [cited 29.04.2025]
41. Sevigny EL. Cannabis and driving ability. Current Opinion in Psychology. 2021. 38:75-9
42. Mills L, Freeman J, Rowland B. Australian daily cannabis users' use of police avoidance strategies and compensatory behaviours to manage the risks of drug driving. Drug and Alcohol Review. 2023. 42(6):1577-86. doi: 10.1111/dar.13705. [cited 18.02.2025]
43. Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ (Clinical research ed). 2012. 344:e536. doi: 10.1136/bmj.e536. [cited 18.02.2025]
44. Victorian Department of Health. Frequently asked questions about medicinal cannabis. 2024. [cited 04.03.2025]
45. Tasmanian Government Department of Health. Medicinal cannabis information for patients and the general public. 2022. [cited 04.03.2025]
46. Transport Victoria. Medicinal cannabis and driving. 2025. [cited 08.04.2025]
47. Fitzroy Legal Service. Driving Law Changes for Medical Cannabis Patients. 2025. [cited 08.04.2025]
48. Centre for Medicinal Cannabis Research and Innovation. Driving. NSW Government, . 2018. [cited 05.05.2025]
49. Safe Work Australia. Drugs and alcohol. n.d. [cited 28.05.2024] Available from:
50. McRae-Clark AL, Gray KM, Baker NL, Sherman BJ, Squeglia L, Sahlem GL, et al. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial. Drug and Alcohol Dependence. 2021. 229. [cited 02.05.2025]
51. Sherman BJ, McRae-Clark AL. Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2016. 36(5):511-35. doi: 10.1002/phar.1747. [cited 01.05.2025]
52. Bhardwaj AK, Mills L, Doyle M, Sahid A, Montebello M, Monds L, et al. A phase III multisite randomised controlled trial to compare the efficacy of cannabidiol to placebo in the treatment of cannabis use disorder: the CBD-CUD study protocol. BMC psychiatry. 2024. 24(1):175. doi: 10.1186/s12888-024-05616-3. [cited 14.05.2025]
53. ACT Policing. ACT Drug Law Reforms. 2024. [cited 05.05.2025]
54. Mathew Alderson. Australia Cannabis Laws: A Comprehensive Guide. 2025. [cited 02.05.2025]
55. Hughes C, Seaar K, Ritter A, Mazerolle L. Monograph No. 27: Criminal justice responses relating to personal use and possession of illicit drugs: The reach of Australian drug diversion programs and barriers and facilitators to expansion 2019. [cited 13.05.2025]
56. Victorian Department of Health. Medicinal cannabis. 2022. [cited 05.05.2025]